These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 2935903)

  • 1. The hematologic consequences of thrombolytic therapy.
    Fletcher AP; Alkjaersig NK
    Prog Hematol; 1986; 14():183-200. PubMed ID: 2935903
    [No Abstract]   [Full Text] [Related]  

  • 2. Thromboelastographic study of fibrinolytic agents.
    Summaria L
    Semin Thromb Hemost; 1995; 21 Suppl 4():63-71. PubMed ID: 8747691
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolytic therapy.
    Kakkar VV; Scully MF
    Br Med Bull; 1978 May; 34(2):191-9. PubMed ID: 148935
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary thrombolysis: hemorrhagic complications.
    Hirsh J
    Can J Cardiol; 1993; 9(6):505-11. PubMed ID: 8221344
    [No Abstract]   [Full Text] [Related]  

  • 5. Theoretic and practical considerations on laboratory monitoring of thrombolytic therapy.
    Conard J; Samama MM
    Semin Thromb Hemost; 1987 Apr; 13(2):212-22. PubMed ID: 3114887
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
    Kwaan HC
    Thromb Diath Haemorrh Suppl; 1973; 56():239-51. PubMed ID: 4617331
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of thrombolytic agents. Implications for therapy of coronary artery thrombosis.
    Marder VJ
    Circulation; 1983 Aug; 68(2 Pt 2):I2-5. PubMed ID: 6683134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic effects of thrombolytic therapy].
    Balduini CL; Gamba G; Bertolino G; Noris P; Previtali M; Ascari E
    Haematologica; 1991 Jun; 76 Suppl 3():281-90. PubMed ID: 1752524
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of thrombolytic agents].
    Laprevote-Heully MC; Lambert H; Larcan A
    Agressologie; 1983 Nov; 24(11):559-65. PubMed ID: 6367511
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological potentials for activating the fibrinolytic system].
    Markwardt F
    Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Side effects of thrombolytic therapy in patients with myocardial infarction].
    Agostoni A; Gardinali M
    Cardiologia; 1995 Dec; 40(12):899-908. PubMed ID: 8901040
    [No Abstract]   [Full Text] [Related]  

  • 12. An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis.
    Marder VJ; Francis CW
    Prog Hemost Thromb; 1984; 7():325-56. PubMed ID: 6241729
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombolytic treatment of thromboembolytic conditions].
    Gormsen J
    Ugeskr Laeger; 1966 Oct; 128(42):1235-45. PubMed ID: 4231392
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator.
    Peuhkurinen K; Risteli L; Jounela A; Risteli J
    Am Heart J; 1996 Jan; 131(1):7-13. PubMed ID: 8554022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current developments in thrombolytic therapy using novel plasminogen activators.
    Seifried E; Tanswell P
    Arzneimittelforschung; 1989 Nov; 39(11):1474-82. PubMed ID: 2695093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic agents and their effects on the haemostatic system.
    Kluft C
    Klin Wochenschr; 1988; 66 Suppl 12():50-4. PubMed ID: 2964542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.
    Ogston D; Douglas AS
    Drugs; 1971; 1(3):228-46. PubMed ID: 4256645
    [No Abstract]   [Full Text] [Related]  

  • 19. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acyl enzymes and pro-urokinase: promising new thrombolytic agents].
    Samama M; Horellou MH; Nguyen G; Conard J
    Haemostasis; 1986; 16 Suppl 4():35-9. PubMed ID: 3095199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.